227 related articles for article (PubMed ID: 33325648)
1. Surveillance for radiation-related late effects in childhood cancer survivors: The impact of using volumetric dosimetry.
Cohen-Cutler S; Olch A; Wong K; Malvar J; Sposto R; Kobierski P; Sura A; Constine LS; Freyer DR
Cancer Med; 2021 Feb; 10(3):905-913. PubMed ID: 33325648
[TBL] [Abstract][Full Text] [Related]
2. Impact of Volumetric Dosimetry on the Projected Cost of Radiation-Related Late Effects Screening After Childhood Cancer: A Real-World Cohort Analysis.
Cohen-Cutler S; Kaplan C; Olch A; Wong K; Malvar J; Constine LS; Freyer DR
Oncologist; 2023 Sep; 28(9):e784-e792. PubMed ID: 37284853
[TBL] [Abstract][Full Text] [Related]
3. Use of electronic patient data storage for evaluating and setting the risk category of late effects in childhood cancer survivors.
Rajala S; Järvelä LS; Huurre A; Grönroos M; Rautava P; Lähteenmäki PM
Pediatr Blood Cancer; 2020 Nov; 67(11):e28678. PubMed ID: 32860665
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer.
Oeffinger KC; Ford JS; Moskowitz CS; Diller LR; Hudson MM; Chou JF; Smith SM; Mertens AC; Henderson TO; Friedman DL; Leisenring WM; Robison LL
JAMA; 2009 Jan; 301(4):404-14. PubMed ID: 19176442
[TBL] [Abstract][Full Text] [Related]
5. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group.
Bardi E; Mulder RL; van Dalen EC; Bhatt NS; Ruble KA; Burgis J; Castellino SM; Constine LS; den Hoed CM; Green DM; Koot BGP; Levitt G; Szonyi L; Wallace WH; Skinner R; Hudson MM; Kremer LCM; Effinger KE; Bresters D
Cancer Treat Rev; 2021 Nov; 100():102296. PubMed ID: 34571378
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
van Dalen EC; Mulder RL; Suh E; Ehrhardt MJ; Aune GJ; Bardi E; Benson BJ; Bergler-Klein J; Chen MH; Frey E; Hennewig U; Lockwood L; Martinsson U; Muraca M; van der Pal H; Plummer C; Scheinemann K; Schindera C; Tonorezos ES; Wallace WH; Constine LS; Skinner R; Hudson MM; Kremer LCM; Levitt G; Mulrooney DA
Eur J Cancer; 2021 Oct; 156():127-137. PubMed ID: 34450551
[TBL] [Abstract][Full Text] [Related]
7. Documentation of Late-Effects Risks and Screening Recommendations for Adolescent and Young Adult Central Nervous System, Soft Tissue, or Bone Tumor Survivors Treated with Radiotherapy in British Columbia, Canada.
Howard AF; Tran J; Aparicio A; Lo A; Ullett A; McKenzie M; Srikanthan A; Goddard K
J Adolesc Young Adult Oncol; 2019 Apr; 8(2):142-148. PubMed ID: 30307359
[TBL] [Abstract][Full Text] [Related]
8. Looking for trouble: Adherence to late-effects surveillance among childhood cancer survivors.
Reppucci ML; Schleien CL; Fish JD
Pediatr Blood Cancer; 2017 Feb; 64(2):353-357. PubMed ID: 27578608
[TBL] [Abstract][Full Text] [Related]
9. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
[TBL] [Abstract][Full Text] [Related]
10. Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.
Hamilton SN; Arshad O; Kwok J; Tran E; Fuchsia Howard A; Serrano I; Goddard K
Support Care Cancer; 2019 Jul; 27(7):2609-2616. PubMed ID: 30467794
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL; Kremer LC; Hudson MM; Bhatia S; Landier W; Levitt G; Constine LS; Wallace WH; van Leeuwen FE; Ronckers CM; Henderson TO; Dwyer M; Skinner R; Oeffinger KC;
Lancet Oncol; 2013 Dec; 14(13):e621-9. PubMed ID: 24275135
[TBL] [Abstract][Full Text] [Related]
12. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
Landier W; Bhatia S; Eshelman DA; Forte KJ; Sweeney T; Hester AL; Darling J; Armstrong FD; Blatt J; Constine LS; Freeman CR; Friedman DL; Green DM; Marina N; Meadows AT; Neglia JP; Oeffinger KC; Robison LL; Ruccione KS; Sklar CA; Hudson MM
J Clin Oncol; 2004 Dec; 22(24):4979-90. PubMed ID: 15576413
[TBL] [Abstract][Full Text] [Related]
13. Impact of the model of long-term follow-up care on adherence to guideline-recommended surveillance among survivors of adolescent and young adult cancers.
Kagramanov D; Sutradhar R; Lau C; Yao Z; Pole JD; Baxter NN; Gupta S; Nathan PC
Cancer Med; 2021 Aug; 10(15):5078-5087. PubMed ID: 34128353
[TBL] [Abstract][Full Text] [Related]
14. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Suh E; Stratton KL; Leisenring WM; Nathan PC; Ford JS; Freyer DR; McNeer JL; Stock W; Stovall M; Krull KR; Sklar CA; Neglia JP; Armstrong GT; Oeffinger KC; Robison LL; Henderson TO
Lancet Oncol; 2020 Mar; 21(3):421-435. PubMed ID: 32066543
[TBL] [Abstract][Full Text] [Related]
15. Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
Mulder RL; Bresters D; Van den Hof M; Koot BG; Castellino SM; Loke YKK; Post PN; Postma A; Szőnyi LP; Levitt GA; Bardi E; Skinner R; van Dalen EC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD008205. PubMed ID: 30985922
[TBL] [Abstract][Full Text] [Related]
16. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.
Zureick AH; Evans CL; Niemierko A; Grieco JA; Nichols AJ; Fullerton BC; Hess CB; Goebel CP; Gallotto SL; Weyman EA; Gaudet DE; Nartowicz JA; Ebb DH; Jones RM; MacDonald SM; Tarbell NJ; Yock TI; Pulsifer MB
Cancer; 2018 May; 124(10):2238-2245. PubMed ID: 29499085
[TBL] [Abstract][Full Text] [Related]
17. Evidence for increased surveillance of executive functioning in adolescent and young adult survivors of childhood cancer.
Lee JL; Gutierrez-Colina A; Meacham LR; Mertens AC; Gilleland Marchak J
Transl Behav Med; 2019 Jul; 9(4):777-784. PubMed ID: 30395335
[TBL] [Abstract][Full Text] [Related]
18. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two models of follow-up care for adult survivors of childhood cancer.
Reynolds K; Spavor M; Brandelli Y; Kwok C; Li Y; Disciglio M; Carlson LE; Schulte F; Anderson R; Grundy P; Giese-Davis J
J Cancer Surviv; 2019 Aug; 13(4):547-557. PubMed ID: 31250352
[TBL] [Abstract][Full Text] [Related]
20. Late somatic sequelae after treatment of childhood cancer in Slovenia.
Erman N; Todorovski L; Jereb B
BMC Res Notes; 2012 May; 5():254. PubMed ID: 22624861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]